Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Oxcarbazepine on Padsevonil PK in Epilepsy
NCT03695094Phase 1Completed
- Sponsor
- UCB
- Start
- Sep 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, open-label trial of padsevonil in epilepsy (2 arms), sponsored by UCB. Primary endpoints: Maximum Observed Plasma Concentration of Padsevonil, Time to Reach Maximum Concentration for Padsevonil and 2 more. Started Sep 2018; status: completed.
02
Drugs
padsevonil
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03695094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03695094.